CR20150593A - POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE - Google Patents

POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE

Info

Publication number
CR20150593A
CR20150593A CR20150593A CR20150593A CR20150593A CR 20150593 A CR20150593 A CR 20150593A CR 20150593 A CR20150593 A CR 20150593A CR 20150593 A CR20150593 A CR 20150593A CR 20150593 A CR20150593 A CR 20150593A
Authority
CR
Costa Rica
Prior art keywords
zeste
inhibitors
homologist
potential
ezh2
Prior art date
Application number
CR20150593A
Other languages
Spanish (es)
Inventor
Jr Charles William Blackledge
Joelle Lorraine Burgess
Neil W Johnson
Jiri Kasparec
Steven David Knight
Iii Louis V Lafrance
Juan I Luengo
William Henry Miller
Kenneth Allen Newlander
Stuart Paul Romeril
Mark Schulz
Dai-Shi Su
Xinrong Tian
Original Assignee
Glaxosmithkline Ip No 2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2014/061012 external-priority patent/WO2014177982A1/en
Application filed by Glaxosmithkline Ip No 2 Ltd filed Critical Glaxosmithkline Ip No 2 Ltd
Publication of CR20150593A publication Critical patent/CR20150593A/en

Links

Abstract

Esta invención se refiere a compuestos novedosos de acuerdo con la Fórmula (I) que son inhibidores del Potenciador de Homólogo Zeste 2 (EZH2), a composiciones farmacéuticas que los contienen, a procedimientos para su preparación y a su uso en terapia para 5 el tratamiento de cánceres.This invention relates to novel compounds according to Formula (I) that are inhibitors of the Zeste 2 Homologous Enhancer (EZH2), to pharmaceutical compositions containing them, to methods for their preparation and their use in therapy for the treatment of cancers

CR20150593A 2013-04-30 2015-10-30 POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE CR20150593A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361817436P 2013-04-30 2013-04-30
US201361842038P 2013-07-02 2013-07-02
US201361907024P 2013-11-21 2013-11-21
PCT/IB2014/061012 WO2014177982A1 (en) 2013-04-30 2014-04-25 Enhancer of zeste homolog 2 inhibitors

Publications (1)

Publication Number Publication Date
CR20150593A true CR20150593A (en) 2016-01-07

Family

ID=55484094

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20150593A CR20150593A (en) 2013-04-30 2015-10-30 POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE

Country Status (1)

Country Link
CR (1) CR20150593A (en)

Similar Documents

Publication Publication Date Title
DOP2015000270A (en) POTENTIAL OF INHIBITORS OF THE HOMOLOGIST OF ZESTE
CL2018003701A1 (en) Heterocyclic compounds as immunomodulators.
CL2018001685A1 (en) Heterocyclic compounds as immuno modulators.
CY1121850T1 (en) DIARYLO MACROCYLES AS REGULATORS OF PROTEIN KINASES
CU20160162A7 (en) DERIVATIVES OF PIRROLIDINA-2,5-DIONA, TO USE AS IDO1 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CL2016001790A1 (en) Derivative compounds and compositions of n-heteroaryl substituted n-azaspirocycloalkane to inhibit shp2 activity.
CL2016003350A1 (en) Lysine specific demethylase-1 inhibitors
CL2017000521A1 (en) Lysine-specific demethylase-1 inhibitors
CL2015002767A1 (en) Therapeutic compounds and compositions
CR20150633A (en) BIPIRAZOL DERIVATIVES AS JAK INHIBITORS
UY36285A (en) COMPOUNDS THAT INHIBIT THE MCL-1 PROTEIN
UY35590A (en) NEW COMPOUNDS FOR CANCER TREATMENT
UY35898A (en) ? SYK INHIBITING COMPOUNDS AND COMPOSITIONS THAT UNDERSTAND THEM ?.
CO2018011819A2 (en) Zeste 2 homolog enhancer inhibitors
UY36758A (en) INHIBITORS OF THE ZESTE 2 HOMOLOGIST POTENTIATOR
EA201790082A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMITILASE-1
CL2017001073A1 (en) 2,4 diamino-quinolia substituted as new anticancer agents
AR100431A1 (en) PIRIDINE PLADIENOLIDE COMPOUNDS AND METHODS OF USE
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
EA201890331A1 (en) PYRIDINODICARBOXAMIDES FOR APPLICATION AS BROMODOUM INHIBITORS AS
CL2017000659A1 (en) Histone Demethylase Inhibitors
BR112015030515A2 (en) zeste homolog 2 inhibitor enhancers
CL2016003074A1 (en) Compounds derived from 2-oxy-2-phenyl-n-5-pyrrolidin-3-ylamino-1,3,4-thiadiazol-2-ylacetamide, pharmaceutical composition gls1 inhibitors and their use to treat cancer.
EA201790604A1 (en) Inhibitors of histonedehylase
SV2016005310A (en) DERIVATIVES OF DIHETEROCICLO LINKED TO CYCLALKYL